Expertise
Skin Health Institute has a proud history of collaborating with international and local pharmaceutical companies as well as National Collaborative Groups on a variety of clinical trials and research projects. The Skin Health Institute is also signatory to an agreement as collaborator with Probity Medical Research, a Canadian-based clinical trials consortium presided over by Dr Kim Papp, who is a world authority on designing, implementing and conducting clinical trials.
Successful treatments approved for use in Australia that were tested by our Clinical Trials Department include:
| Psoriasis | Atopic Dermatitis | Skin Cancer/ Actinic Keratosis | Hidradenitis Suppurativa | Rosacea/Chronic Spontaneous Urticaria |
|---|---|---|---|---|
| Humira | Elidel | Aldara | Humira | Soolantra (Rosacea) |
| Remicade | Staquis | Erivedge | Xolair (CSU) | |
| Cosentyx | Desowen | Picato | ||
| Taltz | Dupixent | PDT Metvix & Daylight PDT | ||
| Tremfya | Upadacitinib | |||
| Ilumya | ||||
| Skirizi | ||||
| Otzela | ||||
| Sekukinumab | ||||
| Sotyktu | ||||
| Enbrel (also for Psoriatic Arthritis) |
